You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 8, August 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

C2 Deficient Systemic Lupus Erythematosus

Its Association With Anti-Ro (SSA) Antibodies

Paul R. Vandersteen, MD; Thomas T. Provost, MD; Robert E. Jordon, MD; Frederic C. McDuffie, MD

Arch Dermatol. 1982;118(8):584-587.


Abstract

• C2 deficiency is the most common complement component deficiency. While individuals with C2 deficiency may be completely normal, a lupus erythematosus—like disease process has developed in some. A 28-year-old woman had a chronic photodermatitis, arthralgias, and mesangial lupus nephritis. She has C2 deficiency associated with an HLA-Dw2 transplantation antigen. Her serum has shown antibodies to the macromolecule Ro (the A antigen in Sjögren's syndrome), while failing to demonstrate antinuclear antibodies in routine laboratory determinations.

(Arch Dermatol 1982;118:584-587)



Author Affiliations

From the Department of Dermatology, the Fargo Clinic and the Division of Dermatology, University of North Dakota (Fargo) Medical School (Dr Vandersteen); the Department of Dermatology, The Johns Hopkins School of Medicine, Baltimore (Dr Provost); the Division of Dermatology, Department of Medicine, The Medical College of Wisconsin (Milwaukee) (Dr Jordon); and the Rheumatology Research Laboratory, the Mayo Clinic, Rochester, Minn (Dr McDuffie). Dr McDuffie is currently at the National Office of the Arithritis Foundation, Atlanta.


Footnotes

Accepted for publication March 28, 1982.

Read in part before the meeting of the Noah Worcester Dermatological Society, Newport Beach, Calif, March 22-28, 1981.

Reprint requests to Fargo Clinic, Fargo, ND 58123 (Dr Vandersteen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lupus Erythematosus Associated With Genetically Determined Deficiency of the Second Component of the Complement
Lipsker et al.
Arch Dermatol 2000;136:1508-1514.
ABSTRACT | FULL TEXT  

Urticarial Vasculitis Progressing to Systemic Lupus Erythematosus
Bisaccia et al.
Arch Dermatol 1988;124:1088-1090.
ABSTRACT  

Lupus Erythematosus Panniculitis With Partial Genetic Deficiency of C2 and C4 in a Child
Taieb et al.
Arch Dermatol 1986;122:576-582.
ABSTRACT  

Immunobiological Significance of the Ro/SSA Antigen-Antibody System
Sontheimer
Arch Dermatol 1985;121:327-330.
ABSTRACT  

Anti-Ro/SSA Antibodies: Association With a Particulate (Large Speckledlike Thread) Immunofluorescent Nuclear Staining Pattern
Wermuth et al.
Arch Dermatol 1985;121:335-338.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.